HOME >> MEDICINE >> NEWS
Penn researchers announce results of Phase I trial using combretastatin drug

(Philadelphia, PA) -- New approaches are needed to treat solid malignant tumors that cannot be removed surgically and are resistant to traditional powerful chemotherapy drugs. In a Phase I clinical trial, a team of researchers at the University of Pennsylvania Cancer Center has found that patients with solid cancerous tumors were able to safely tolerate a new drug, originally derived from a South African willow bush, that interacts with the tumor's blood supply. James P. Stevenson, MD, assistant professor of medicine at Penn and lead author of the study, will present these findings at the 91st American Association of Cancer Research Meeting on Tuesday, April 4, 2000 in San Francisco.

Combretastatin A4 phosphate is a drug that is classified as a vascular targeting agent. It selectively targets and reduces or destroys blood vessels supplying malignant tumors while sparing the vasculature of normal tissues. Vascular targeting agents like combretastatin attack proliferating blood vessels that already exist, whereas angiogenesis inhibitors generally stop new blood vessels from developing.

In this study, 29 patients with a range of solid tumors, unresponsive to traditional chemotherapy, were treated with a daily intervenous dose of combretastatin for five consecutive days every three weeks. All of the patients were given CT scans before and at the end of the treatment cycle to determine changes in tumor blood supply. Nine patients who were given the highest dose of combretastatin were monitored via MRI. Dr. Stevenson's team found evidence of a decrease in blood flow to the tumor following combretastatin therapy in five of the nine patients who were followed by MRI.

"These early results are promising and suggest that combretastatin may affect tumor blood supply," says Stevenson. "We will continue investigating this drug for its potential benefits in fighting advanced cancers."

T
'"/>

Contact: Sue Montgomery
sue.montgomery@uphs.upenn.edu
215-349-5657
University of Pennsylvania School of Medicine
3-Apr-2000


Page: 1 2

Related medicine news :

1. Indiana University researchers closer to helping hearing-impaired using stem cells
2. Protein that helps skin cancer spread identified by Stanford researchers
3. US life expectancy about to decline, researchers say
4. Gene for age-related macular degeneration discovered by Yale researchers
5. Dartmouth researchers find where musical memories are stored in the brain
6. Columbia researchers receive $3 million to combat genetic killer of infants & toddlers
7. US cancer researchers launch first American-Israeli cancer conference
8. USC dental researchers develop first test for predicting cavities in children
9. Young blood revives aging muscles, Stanford researchers find
10. Uric acid may help reduce effects of spinal cord injury, Jefferson researchers find
11. Age should not be a factor in determining heart transplantation eligibility, researchers say

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2018)... FRANCISCO (PRWEB) , ... November 15, 2018 , ... Through ... microbiome research support in study design, planning, sample collection, and analysis to a team ... a randomized controlled trial to test the effects on the microbiome of a low-fat ...
(Date:11/15/2018)... ... November 15, 2018 , ... The National Cancer Institute estimates that ... is the primary risk factor for cancer and we typically associate the disease with ... of 45. And with aggressive treatment and advanced therapies, increasing numbers of these patients ...
(Date:11/15/2018)... , ... November 15, 2018 , ... West Virginia and ... and 45th in the country when it comes to the number of weight-loss surgeries ... analysis of factors that may determine utilization of bariatric surgery in the 50 states ...
(Date:11/15/2018)... ... November 15, 2018 , ... Access today ... paperless, web-based eForms solution for hospitals . This release features tight integration with ... directly from any of these systems, have patients electronically sign them on tablets, ...
(Date:11/15/2018)... ... November 15, 2018 , ... GoInvo, a ... “Loneliness in Our Human Code”, ( https://www.goinvo.com/vision/loneliness-in-our-human-code/ ) the latest in a series ... visual essay explores how social determinants of health, with a focus on loneliness, ...
Breaking Medicine News(10 mins):
(Date:11/15/2018)... ... November 15, 2018 , ... Triple W, an innovator of ... version of the companion app for DFree®, the first wearable device for incontinence that ... , seniors, children and disabled people with bladder control issues have a convenient and ...
(Date:11/15/2018)... LOS ANGELES (PRWEB) , ... November 15, 2018 ... ... the potential of cosmetic and reconstructive surgery in their lives will soon be ... MD. , After months of work, Alton Ingram, MD, created the now-popular blog ...
(Date:11/15/2018)... ... November 15, 2018 , ... ... today announced a strategic partnership with Formativ Health, a technology-enabled, health-services company, ... perform platform integrations that connect Formativ Health’s clients’ Healthcare IT to the ...
Breaking Medicine Technology:
Cached News: